Länder Analysen: Singapur

18.06.18Flextronics International BuyStandpoint Research
18.05.18Broadcom OutperformCowen and Company, LLC
16.05.18VolitionRX BuyMaxim Group
14.05.18VolitionRX BuyThe Benchmark Company
26.03.18Broadcom OverweightBarclays Capital
26.03.18Broadcom buyGoldman Sachs Group Inc.
19.03.18WAVE Life Sciences BuyMizuho
16.03.18Broadcom BuyCanaccord Adams
16.03.18Broadcom BuyDrexel Hamilton
15.03.18Broadcom BuyDeutsche Bank AG
01.02.18Broadcom BuyB. Riley FBR, Inc.
26.01.18Flextronics International BuyNeedham & Company, LLC
07.12.17Broadcom BuyB. Riley FBR, Inc.
07.12.17Broadcom OutperformCowen and Company, LLC
07.12.17Broadcom BuyMizuho
20.11.17Broadcom Top PickRBC Capital Markets
14.11.17Sea BuyStifel, Nicolaus & Co., Inc.
02.11.17Broadcom BuyB. Riley FBR, Inc.
11.10.17Broadcom Top PickRBC Capital Markets
25.08.17Broadcom OutperformCowen and Company, LLC
24.08.17Broadcom BuyCanaccord Adams
18.07.17Flextronics International BuyNeedham & Company, LLC
02.06.17Broadcom BuyDeutsche Bank AG
02.06.17Broadcom BuyCraig Hallum
02.06.17Broadcom OutperformCowen and Company, LLC
31.05.17Broadcom Top PickRBC Capital Markets
10.03.17Broadcom OverweightBarclays Capital
02.03.17Broadcom Top PickRBC Capital Markets
02.03.17Broadcom BuyCraig Hallum
02.03.17Broadcom BuyDrexel Hamilton
02.03.17Broadcom OutperformCowen and Company, LLC
28.02.17Broadcom OverweightBarclays Capital
21.02.17Flextronics International OutperformRBC Capital Markets
21.02.17Broadcom Top PickRBC Capital Markets
15.02.17WAVE Life Sciences BuyH.C. Wainwright & Co.
08.02.17Broadcom Top PickRBC Capital Markets
27.01.17Flextronics International BuyNeedham & Company, LLC
24.05.16Flextronics International HoldStandpoint Research
15.01.16Flextronics International OutperformRBC Capital Markets
02.12.15Kenon HoldDeutsche Bank AG
Seite: 1234567

Aktuelle News zu

23:03 UhrGCL System Integration stellt hocheffiziente Module auf Intersolar aus
22:23 UhrBERLINER MORGENPOST: Erdogans hohes Risiko / Leitartikel von Gudrun Büscher
21:33 UhrBERLINER MORGENPOST: Berlin braucht "Große Gelbe" / Kommentar von Andreas Abel
20:59 UhrGCL System Integration stellt hocheffiziente Module auf Intersolar aus
20:23 UhrHanergy stellt seine jüngsten Innovationen auf der Intersolar Europe aus
19:47 UhrPositionen der deutschen und europäischen Verlegerverbände zum EU-Leistungsschutzrecht
19:45 UhrAthletic Brewing Company Launches State-Wide in Connecticut
19:30 UhrOne Drop Announces Blood Glucose Prediction and Automated Decision Support
19:01 UhrDiabeloop Insulin Delivery System May Significantly Improve Glycemic Control for People with Type 1 Diabetes
18:43 UhrThe Stars Group gibt Start des privaten Angebots von unbesicherten Schuldscheinen in Höhe von 750 Millionen USD bekannt
18:43 UhrFully Implantable, Continuous Glucose Monitoring Sensor Provided Accuracy for Six Months in Adolescents and Adults with Type 1 Diabetes
18:43 UhrDual-Hormone, Artificial Pancreas with Insulin and Pramlintide Significantly Improves Glucose Levels, Compared to Insulin-Only Artificial Pancreas
18:40 UhrOmnipod® Hybrid Closed-Loop Insulin Delivery System Significantly Improves Glycemic Control in Adults with Type 1 Diabetes
18:30 UhrVIA Opens Newest Park & Ride Facility in Stone Oak
18:30 UhrVieles spricht für Emerging Markets
18:27 UhrSpotify räumt beim Cannes Lions Festival of International Creativity ab
18:19 UhrHanergy stellt seine jüngsten Innovationen auf der Intersolar Europe aus
17:00 UhrImportant Questions To Ask Car Insurance Agents
16:57 UhrDer Tagesspiegel: Schäuble: Merkel bleibt bei einer Richtlinienentscheidung keine Wahl
16:30 UhrUnifor locals reach tentative agreements with Bombardier
16:30 UhrUnifor locals reach tentative agreements with Bombardier
16:23 UhrSpotify räumt beim Cannes Lions Festival of International Creativity ab
16:12 UhrTresiba® demonstrated significantly lower A1C and rates of hypoglycaemia versus insulin glargine U-300 in real-world evidence study
16:12 UhrTresiba® Demonstrated Significantly Improved Blood Sugar Control and Lower Rates of Hypoglycaemia Versus Insulin Glargine U300 in Real-World Evidence Study
16:12 UhrTresiba® Demonstrated Significantly Improved Blood Sugar Control and Lower Rates of Hypoglycaemia Versus Insulin Glargine U300 in Real-World Evidence Study
16:09 UhrOzempic® provided greater weight reductions for adults with a baseline BMI =25kg/m2 than those with lower baseline BMI <25kg/m2, in a SUSTAIN 7 post-hoc analysis
16:09 UhrOzempic® Provided Greater Weight Reductions for Adults With a Baseline BMI =25kg/m2 Than Those With Lower Baseline BMI <25kg/m2, in a SUSTAIN 7 Post-hoc Analysis
16:09 UhrOzempic® Provided Greater Weight Reductions for Adults With a Baseline BMI =25kg/m2 Than Those With Lower Baseline BMI <25kg/m2, in a SUSTAIN 7 Post-hoc Analysis
16:06 UhrOral semaglutide demonstrated significant reduction in blood sugar vs placebo in PIONEER 1 trial
16:06 UhrOral Semaglutide Demonstrated Significant Reduction in Blood Sugar vs Placebo in PIONEER 1 Trial
16:06 UhrOral Semaglutide Demonstrated Significant Reduction in Blood Sugar vs Placebo in PIONEER 1 Trial
16:03 UhrOne Third of Participants in a Workforce Study Reduce Risk for Diabetes after Employer Wellness Screening and Behavioral Counseling, Finds Quest Diagnostics Study
16:00 UhrGNation Shows That Gamers Care About Charity at E3 2018
16:00 UhrDr. John R. Burroughs of Springs Aesthetics Now Offering vFit PLUS Feminine Wellness Treatment Device
16:00 UhrReal-World Evidence Shows Oral INVOKANA® (canagliflozin) Results in Greater Weight Loss and Treatment Adherence Than Injectable GLP-1 Receptor Agonists in Type 2 Diabetes Patients
16:00 UhrFractyl Announces Presentation of Key Scientific Research at ADA 2018 Indicating That Modern Diets Durably Alter Duodenal Lining, Highlighting the Intestine's Role in Type 2 Diabetes and NASH
16:00 UhrNew Data Presented at the American Diabetes Association 78th Scientific Sessions® Reinforce Potential of Lilly's Ultra Rapid Lispro in People with Type 1 and Type 2 Diabetes
16:00 UhrJardiance® reduced risk of kidney disease progression in adults with type 2 diabetes and established cardiovascular (CV) disease independent of control of conventional CV risk factors
16:00 UhrADT NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against ADT Inc. - ADT
16:00 UhrTresiba® demonstrated significantly improved blood sugar control and lower rates of hypoglycemia versus insulin Toujeo® in real-world evidence study
16:00 UhrTresiba® demonstrated significantly improved blood sugar control and lower rates of hypoglycemia versus insulin Toujeo® in real-world evidence study
15:47 UhrGaumard's Growing Family Takes Center Stage at AWHONN '18
15:30 UhrPflichtblatt für Ihr Geld: Neue €uro am Sonntag
15:00 UhrBay Shore Area Dealership Partners with Animal Rescue for Adoption Event
15:00 UhrStatement by the Prime Minister on the National Day of Remembrance for Victims of Terrorism
15:00 UhrStatement by the Prime Minister on the National Day of Remembrance for Victims of Terrorism
14:53 UhrEin Prosit auf die Bierbranche: Das sind die wahren WM-Sieger
14:05 UhrSignificant blood sugar improvement with Xultophy® 100/3.6 compared to insulin glargine U-100 when used as add-on to oral diabetes medications
14:05 UhrSignificant Blood Sugar Improvement With Xultophy® Compared to Insulin Glargine U-100 When Used as Add-On to Oral Diabetes Medications
14:00 UhrNew Data Show Amgen's Repatha® (evolocumab) Significantly Reduced LDL-C And Non-HDL-C In High-risk Patients With Type 2 Diabetes

Online Brokerage über finanzen.net

Das Beste aus zwei Welten: Handeln Sie für nur 5 Euro Orderprovision* pro Trade unmittelbar aus der Informationswelt von finanzen.net!
Zur klassischen Ansicht wechseln
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Deutsche Bank AG514000
Daimler AG710000
Apple Inc.865985
Scout24 AGA12DM8
Amazon906866
TeslaA1CX3T
Volkswagen (VW) AG Vz.766403
Allianz840400
Alphabet C (ex Google)A14Y6H
MasterCard Inc.A0F602
Netflix Inc.552484
Facebook Inc.A1JWVX
E.ON SEENAG99
BMW AG519000
Deutsche Telekom AG555750